BR100 Increased By (0.21%)
BR30 Increased By (0.21%)
KSE100 Increased By (0.24%)
KSE30 Increased By (0.2%)
AGHA 6.50 Increased By ▲ 0.05 (0.78%)
BECO 4.18 Increased By ▲ 0.02 (0.48%)
BML 56.25 Decreased By ▼ -1.06 (-1.85%)
BOP 28.29 Increased By ▲ 0.14 (0.5%)
CNERGY 12.53 Increased By ▲ 0.12 (0.97%)
CSIL 5.40 Increased By ▲ 0.04 (0.75%)
FCCL 51.50 Decreased By ▼ -0.16 (-0.31%)
FFL 13.89 Decreased By ▼ -0.01 (-0.07%)
FNEL 1.09 Increased By ▲ 0.01 (0.93%)
KEL 5.70 Decreased By ▼ -0.02 (-0.35%)
KOSM 5.32 Decreased By ▼ -0.01 (-0.19%)
LOTCHEM 24.39 Increased By ▲ 0.14 (0.58%)
MLCF 89.75 Increased By ▲ 0.11 (0.12%)
NBP 156.96 Increased By ▲ 0.39 (0.25%)
NCPL 49.62 Increased By ▲ 2.60 (5.53%)
NPL 55.00 Increased By ▲ 3.04 (5.85%)
OGDC 299.92 Decreased By ▼ -0.09 (-0.03%)
PACE 9.30 Increased By ▲ 0.04 (0.43%)
PAEL 33.09 Increased By ▲ 0.08 (0.24%)
PIBTL 13.22 Increased By ▲ 0.03 (0.23%)
PPL 214.23 Decreased By ▼ -0.09 (-0.04%)
PRL 100.25 Decreased By ▼ -1.19 (-1.17%)
PTC 52.35 Increased By ▲ 0.11 (0.21%)
SSGC 23.20 Increased By ▲ 0.05 (0.22%)
TBL 9.05 Decreased By ▼ -0.04 (-0.44%)
TELE 7.03 Increased By ▲ 0.05 (0.72%)
TPL 22.41 Increased By ▲ 0.37 (1.68%)
TPLP 11.75 Increased By ▲ 0.06 (0.51%)
TREET 22.99 Increased By ▲ 0.19 (0.83%)
TRG 57.52 Increased By ▲ 0.39 (0.68%)
اردو
Android App
Print Edition Dollar to PKR
Daily Petrol Prices IMF-World Bank meetings Intl Oil Prices Iran-US war Gold Rates Podcasts PSX Notices
World

AstraZeneca to supply COVID-19 antibody cocktail to Singapore

Published Updated
Save
1 min
Comments
By Reuters

SINGAPORE: AstraZeneca said on Friday it will supply Singapore with its COVID-19 antibody cocktail, Evusheld, by the end of the year.

Evusheld can act as another layer of protection, alongside vaccines, for people who are at high risk of COVID-19 infection, according to AstraZeneca's statement.

The company did not specify how many courses of the treatment would be supplied to the Southeast Asian city-state.

The US Food and Drug Administration on Wednesday authorised the use of Evusheld to prevent COVID-19 infections in individuals with weak immune systems or a history of severe side effects from coronavirus vaccines.

AstraZeneca

Comments

Comments are closed for this article.

More Stories

Browse all stories